Advertisement
Singapore markets open in 5 hours 18 minutes
  • Straits Times Index

    3,314.14
    +8.12 (+0.25%)
     
  • S&P 500

    5,461.18
    -3.44 (-0.06%)
     
  • Dow

    39,446.72
    +296.39 (+0.76%)
     
  • Nasdaq

    17,558.32
    -131.04 (-0.74%)
     
  • Bitcoin USD

    60,044.59
    -4,037.90 (-6.30%)
     
  • CMC Crypto 200

    1,243.31
    -66.41 (-5.07%)
     
  • FTSE 100

    8,281.55
    +43.83 (+0.53%)
     
  • Gold

    2,344.50
    +13.30 (+0.57%)
     
  • Crude Oil

    81.66
    +0.93 (+1.15%)
     
  • 10-Yr Bond

    4.2480
    -0.0090 (-0.21%)
     
  • Nikkei

    38,804.65
    +208.18 (+0.54%)
     
  • Hang Seng

    18,027.71
    -0.81 (-0.00%)
     
  • FTSE Bursa Malaysia

    1,589.66
    -0.71 (-0.04%)
     
  • Jakarta Composite Index

    6,889.17
    -6,879.98 (-49.97%)
     
  • PSE Index

    6,272.46
    +113.98 (+1.85%)
     

Mastercard (MA) and HealthLock Unite to Reduce Medical Fraud

Mastercard Incorporated MA partnered with HealthLock to protect millions of Americans from claim errors, medical bill frauds and overcharges. Healthcare expenditures are projected to reach $6.2 trillion by 2028, giving rise to more complexities and inefficiencies. This partnership aims to reduce complications and is expected to protect consumers' data and save costs.

This move bodes well for Mastercard, which is focused on protecting customer data and creating better security. Through this partnership, HealthLock’s analytics-based services can be used by millions of Mastercard users for no extra fee. In addition, the customers will also receive better rates for subscriptions and a free 90-day trial of HealthLock’s premium service.

Through HealthLocks’ unique value proposition, Mastercard will be able to retain issuer clients by enhancing its existing offerings. Mastercard issuers will benefit by gaining consumers’ trust as they ensure the privacy and security of medical data. As consumers save money on healthcare costs, as a byproduct of this move, issuers can drive incremental revenues and increase deposits.

Medical overbilling, abuse and fraud cost Americans $325 billion annually. Medical data fraud is on the rise and will continue to soar higher; hence consumers need to protect their data. As Mastercard collaborates with HealthLock, consumers are assisted in assessing every medical insurance claim and keeping them organized. More than half of the medical bills contain errors, and this move will help combat the same.

ADVERTISEMENT

Mastercard has unmatchable experience in combating frauds and stands on its ground for innovation in data security. Mastercard’s partnership with HealthLock to enhance its technological footprint is likely to boost the top line in the future by adding value to the company’s existing offerings.

Price Performance

Shares of Mastercard have gained 12.9% in the past year compared with the industry’s growth of 5.2%.

Zacks Investment Research
Zacks Investment Research


Image Source: Zacks Investment Research

Zacks Rank & Key Picks

Mastercard currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks from the Financial Transaction Services industry are PagSeguro Digital Ltd. PAGS, Remitly Global, Inc. RELY and Repay Holdings Corporation RPAY. PagSeuro Digital sports a Zacks Rank #1 (Strong Buy), while Remitly Global and Repay Holdings carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The bottom line of PagSeguro Digital outpaced estimates in each of the trailing four quarters, the average surprise being 33%.

The Zacks Consensus Estimate for PAGS’s 2023 earnings suggests an improvement of 4.4%, while the same for revenues indicates growth of 8.1% from the corresponding year-ago reported figures.

Remitly Global’s bottom line outpaced estimates in two of the trailing four quarters while it missed the other two, the average surprise being 8.2%.

The Zacks Consensus Estimate for RELY’s 2023 revenues indicates a 36.8% rise from the prior-year reported figures.

The bottom line of Repay Holdings outpaced the Zacks Consensus Estimate in three of the trailing four quarters, while it missed once, the average surprise being 4.6%.

The Zacks Consensus Estimate for RPAY’s 2024 earnings indicates a 9.6% rise, while the same for revenues suggests 11.8% growth from the respective prior-year estimated figures.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Mastercard Incorporated (MA) : Free Stock Analysis Report

Remitly Global, Inc. (RELY) : Free Stock Analysis Report

PagSeguro Digital Ltd. (PAGS) : Free Stock Analysis Report

Repay Holdings Corporation (RPAY) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research